Vetnosis publishes Innovation Insight

Edinburgh, UK - 24^th September 2009 - Vetnosis publishes Innovation Insight

Vetnosis has published Innovation Insight, the first independent global analysis and benchmarking study of veterinary pharmaceutical innovation.

Innovation is a key driver of profitable growth but also represents one of the animal health industry's largest costs and greatest risks.  An in-depth, comprehensive analysis of veterinary pharmaceutical innovation is critical business intelligence for any innovation-led organization that wants to understand its competitors' strategies and successes and benchmark its innovation against its peers.

"The animal health industry invests $1 billion annually to discover and develop innovative medicines that meet the needs of veterinarians, farmers and pet owners" said Camilla Kidd MA VetMB MRCVS, Senior Consultant and Study Lead.  "During the development of Innovation Insight we have analysed thousands of product approvals and created an Innovation Index to benchmark company performance."

Innovation Insight is a 331 slide report that delivers innovation analysis and benchmarking by company, species, category, country and approval type/source for:

• Innovation Inde
• Approval number
• Novel active pharmaceutical ingredients (APIs)
• 
  

Adding to this, Julie van den Driesche, Senior Analyst remarked, "Innovation Insight is a must have report for any innovation-led company, containing unique company benchmarking and innovation analysis by company, species, category, country and approval type since 2000."

For further information please visit https://www.vetnosis.com to download a Brochure or contact Tim Evans +44 (0)131 718 0772.